![Kirk Rosemark](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profil
Kirk Rosemark is currently SVP-Regulatory Affairs & Quality Assurance at Xencor, Inc. Formerly, Mr. Rosemark was VP-Regulatory Affairs & Quality Assurance at NeoPharm, Inc. from 2003 to 2014, VP-Regulatory Affairs & Quality Assurance at Exelixis, Inc. from 2003 to 2014, VP-Regulatory Affairs & Quality Assurance at CymaBay Therapeutics, Inc. from 2015 to 2017, and Vice President-Regulatory Affairs at BeOne Medicines USA, Inc. from 2017 to 2019.
Mr. Rosemark completed undergraduate education at Cleveland State University.
Aktive Positionen von Kirk Rosemark
| Unternehmen | Position | Beginn |
|---|---|---|
| XENCOR, INC. | General Counsel | - |
Ehemalige bekannte Positionen von Kirk Rosemark
| Unternehmen | Position | Ende |
|---|---|---|
BeiGene USA, Inc.
 BeiGene USA, Inc. Pharmaceuticals: MajorHealth Technology Manufactures biopharmaceutical products | General Counsel | 01.06.2019 |
| CYMABAY THERAPEUTICS, INC. | General Counsel | 01.04.2017 |
| EXELIXIS, INC. | Corporate Officer/Principal | 01.11.2014 |
NeoPharm, Inc.
 NeoPharm, Inc. BiotechnologyHealth Technology Provides drug research, development and commercialization services | General Counsel | 01.01.2014 |
Ausbildung von Kirk Rosemark
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
70
Beziehungen ersten Grades
6
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 6 |
|---|---|
NeoPharm, Inc.
NeoPharm, Inc. BiotechnologyHealth Technology Provides drug research, development and commercialization services | Health Technology |
Exelixis, Inc.
 Exelixis, Inc. Pharmaceuticals: MajorHealth Technology Operates as a cancer drug discovery company | Health Technology |
CymaBay Therapeutics, Inc.
 CymaBay Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics for people with life-threatening diseases | Health Technology |
Xencor, Inc.
 Xencor, Inc. BiotechnologyHealth Technology Develops therapeutics to treat autoimmune and allergic diseases, cancer and other conditions | Health Technology |
Cleveland State University
 Cleveland State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
BeiGene USA, Inc.
BeiGene USA, Inc. Pharmaceuticals: MajorHealth Technology Manufactures biopharmaceutical products | Health Technology |
